載入...
Selective blood sampling for FGF-23 in tumor-induced osteomalacia
Tumor-induced osteomalacia (TIO) is caused by the hormone fibroblast growth factor 23 (FGF-23). It is mainly produced in the tissue of mesenchymal tumors. Patients with TIO frequently suffer from a chronic decompensated pain syndrome and/or muscle weakness with postural deformity. Despite the severi...
Na minha lista:
| 發表在: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Bioscientifica Ltd
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5633052/ https://ncbi.nlm.nih.gov/pubmed/29026610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-17-0006 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|